Table 3.
|
Cell delivery mode |
||||
---|---|---|---|---|---|
Indications | i.v. | Intraorgan | Membrane/gel | 3D | Total |
Cardiovascular | |||||
Peripheral artery disease | 3 | 53 | 56 | ||
Cardiomyopathy | 12 | 12 | |||
Heart failure | 33 | 33 | |||
Myocardial ischemia | 47 | 64 | 111 | ||
Bypass graft | 16 | 16 | |||
Valve replacement | |||||
Ulcer | 150 | 150 | |||
Other | 23 | 23 | |||
Musculoskeletal | |||||
Bone repair (maxillofacial) | 1 | 1 | 2 | ||
Bone repair (orthopedics) | 22 | 46 | 68 | ||
Osteogenesis imperfecta | 1 | 1 | |||
Cartilage repair | 60 | 11 | 20 | 91 | |
Muscle repair | |||||
Tendon/ligament | 5 | 5 | |||
Reconstructive surgery | 1 | 1 | |||
Other | 17 | 17 | |||
Neurological | |||||
Parkinson's | |||||
Peripheral nerve regeneration | |||||
Other | 3 | 13 | 16 | ||
Epithelial | |||||
Skin reconstruction | 51 | ||||
Cornea repair | 27 | 27 | |||
Organ failure | 10 | 10 | |||
Diabetes | |||||
Liver insufficiency | 2 | 2 | |||
Other | |||||
Autoimmune | |||||
Neurological | 80 | 80 | |||
Rheumatological | 2 | 2 | |||
Gastrointestinal | 5 | ||||
Other | 13 | 3 | 16 | ||
Graft vs. host disease | 19 | 19 | |||
Total | 118 | 390 | 239 | 67 | 814 |
Data only from extended questionnaire.
i.v., intravenous.